Nutraceutical Excipients Market Analysis and Forecast to 2031: By Type (Functional Beverage, Functional Food, and Dietary Supplements), Form (Capsules and Tablets, Liquid, Powder, Others), Sales Channel (Hypermarkets/Supermarkets, Specialty Stores, Pharmacies, and Online Channels), and Region

In the pharmaceutical industry, nutraceutical excipients are substances that are added to a medication to improve its efficacy or to make it more palatable. Nutraceutical excipients can be either active or inactive ingredients. Active ingredients are those that have a pharmacological effect on the body, while inactive ingredients are those that do not. Excipients are typically added to medications in very small amounts and are not intended to have any therapeutic effect.

Some common excipients include binders, fillers, lubricants, sweeteners, and flavorings. Binders are substances that help to hold the active ingredients together so that they can be evenly distributed when the medication is taken. Fillers are used to bulk up the medication so that it can be taken in the correct dosage. Lubricants help to prevent the active ingredients from sticking to the sides of the pill or capsule. Sweeteners make the medication more palatable, while flavorings can mask the taste of the active ingredients.

Nutraceutical excipients are generally considered to be safe for most people. However, some people may be allergic to certain excipients, and it is always important to read the label carefully to make sure that you are not allergic to any of the ingredients.

Key Trends

Some of the key trends in nutraceutical excipients technology include:

  1. Natural and organic ingredients are becoming increasingly popular in the nutraceutical excipients space as consumers become more health-conscious.
  2. Functional ingredients are also gaining popularity as they offer additional health benefits beyond basic nutrition.
  3. Delivery systems are becoming more sophisticated as companies strive to improve the absorption and bioavailability of nutraceuticals.
  4. Safety and efficacy are also becoming major concerns as more people take nutraceuticals for preventative health purposes.
Key Drivers

The key drivers of the Nutraceutical Excipients market are the increasing demand for nutraceuticals and functional foods, the growing awareness of the health benefits of nutraceuticals, and the increasing disposable incomes. The other drivers include the changing lifestyle, the aging population, and the growing health concerns.

The demand for nutraceuticals is increasing due to the growing awareness of the health benefits of these products. The nutraceuticals are used to improve the health and well-being of the consumers. The functional foods are gaining popularity as they help in the prevention and treatment of various diseases. The nutraceuticals excipients are used in the manufacturing of these products.

The aging population is one of the major drivers of the nutraceuticals market. The older people are more prone to the chronic diseases and they need these products for the prevention and treatment of these diseases.

The disposable incomes of the people are increasing which is another driver of this market. The people are willing to spend more on the health products.

The nutraceuticals excipients are used in the manufacturing of various products such as dietary supplements, functional foods, and pharmaceuticals. The excipients are used to improve the stability, texture, and taste of the products. They are also used to enhance the bioavailability of the active ingredients.

Restraints & Challenges

There are a few key restraints and challenges in the Nutraceutical Excipients market. One of the main restraints is the cost of raw materials. The cost of raw materials has been on the rise in recent years, which has led to an increase in the cost of finished products. This has put pressure on margins and has led to a decline in demand for nutraceutical excipients.

Another key challenge facing the nutraceutical excipients market is the stringent regulatory environment. The regulatory environment for nutraceuticals is constantly changing and becoming more stringent. This makes it difficult for companies to keep up with the latest regulations and to develop new products that meet the changing regulations.

The last key challenge facing the nutraceutical excipients market is the competition from other ingredients and products. There are a number of other ingredients and products that are used in the manufacture of nutraceuticals. These products are often cheaper and easier to use than excipients. This makes it difficult for companies to compete on price and to differentiate their products from the competition.

Market Segments

The Nutraceutical Excipients Market is segmented on the basis of type, form, sales channel, and region. Based on type, the global market is bifurcated into functional beverage, functional food, and dietary supplements. By form, the market is segmented into capsules and tablets, liquid, powder, and others. Based on sales channel, the global market is studied across hypermarkets/supermarkets, specialty stores, pharmacies, and online channels. Region-wise, the market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World.

Key Players

The Nutraceutical Excipients Market report includes players such a Archer Daniels Midland Company, BASF SE, Cargill, Inc., Danone, DuPont de Nemours, Inc., General Mills Inc., Koninklijke DSM N.V., Nestle S.A., PepsiCo, Inc., and Yakult Honsha Co., Ltd.

Why GIS?

Table of Contents

Chapter 1. Market Introduction
1.1. Objectives of the Study
1.2. Market Definition and Research & Scope
1.3. Research Methodologies
1.4. Market Estimation Techniques

Chapter 2. Executive Summary
2.1. Summary
2.2. Key Highlights of the Market

Chapter 3. Pharmaceutical Excipients Market Outlook
3.1. Pharmaceutical Excipients Market segmentation
3.2. Market Dynamics
3.2.1. Market Drivers
3.2.1.1. Driver 1
3.2.1.2. Driver 2
3.2.1.3. Driver 3
3.2.2. Market Restraints
3.2.2.1. Restraint 1
3.2.2.2. Restraint 2
3.2.3. Market Opportunities
3.2.3.1. Opportunity 1
3.2.3.2. Opportunity 2
3.3. Porter’s Five Forces Analysis
3.3.1. Threat of New Entrants
3.3.2. Threat of Substitutes
3.3.3. Bargaining Power of Buyers
3.3.4. Bargaining Power of Supplier
3.3.5. Competitive Rivalry
3.4. PESTLE Analysis
3.5. Value Chain Analysis
3.5.1. Raw Material Suppliers
3.5.2. Manufacturers
3.5.3. Wholesalers and/or Retailers
3.6. Impact of the Russia and Ukraine War on the Pharmaceutical Excipients Market

Chapter 4. Economic Impact of COVID-19
4.1. Overall Impact of COVID-19
4.2. Impact of COVID On the Pharmaceutical Excipients Market
4.3. Economic Impact Analysis

Chapter 5. Pharmaceutical Excipients Market By Product
5.1. Market Overview
5.2. Inorganic Chemicals
5.2.1. Market Size and Forecast, 2021-2031 ($Million)
5.2.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
5.3. Organic Chemicals
5.3.1. Market Size and Forecast, 2021-2031 ($Million)
5.3.2. Market Size and Forecast, by Region, 2021-2031 ($Million)

Chapter 6. Pharmaceutical Excipients Market By Type
6.1. Market Overview
6.2. Functional Beverage
6.2.1. Market Size and Forecast, 2021-2031 ($Million)
6.2.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
6.3. Functional Food
6.3.1. Market Size and Forecast, 2021-2031 ($Million)
6.3.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
6.4. Others
6.4.1. Market Size and Forecast, 2021-2031 ($Million)
6.4.2. Market Size and Forecast, by Region, 2021-2031 ($Million)

Chapter 7. Pharmaceutical Excipients Market By Functionality
7.1. Market Overview
7.2 Fillers and Diluents

7.3.1. Market Size and Forecast, 2021-2031 ($Million)
7.3.2. Market Size and Forecast, by Region, 2021-2031 ($Million)

7.3 Binders

7.3.1. Market Size and Forecast, 2021-2031 ($Million)
7.3.2. Market Size and Forecast, by Region, 2021-2031 ($Million)

7.4 Suspension and Viscosity Agents

7.3.1. Market Size and Forecast, 2021-2031 ($Million)
7.3.2. Market Size and Forecast, by Region, 2021-2031 ($Million)

7.5 Coatings

7.3.1. Market Size and Forecast, 2021-2031 ($Million)
7.3.2. Market Size and Forecast, by Region, 2021-2031 ($Million)

7.6 Flavoring Agents

7.3.1. Market Size and Forecast, 2021-2031 ($Million)
7.3.2. Market Size and Forecast, by Region, 2021-2031 ($Million)

7.7 Disintegrants

7.3.1. Market Size and Forecast, 2021-2031 ($Million)
7.3.2. Market Size and Forecast, by Region, 2021-2031 ($Million)

7.8 Colorants

7.3.1. Market Size and Forecast, 2021-2031 ($Million)
7.3.2. Market Size and Forecast, by Region, 2021-2031 ($Million)

7.9 Preservatives

7.3.1. Market Size and Forecast, 2021-2031 ($Million)
7.3.2. Market Size and Forecast, by Region, 2021-2031 ($Million)

7.10 Other Functionalities.
7.2.1. Market Size and Forecast, 2021-2031 ($Million)
7.2.2. Market Size and Forecast, by Region, 2021-2031 ($Million)

Chapter 8. Pharmaceutical Excipients Market, by Region
8.1. Overview
8.2. North America
8.2.1. Key Market Trends and Opportunities
8.2.2. North America Pharmaceutical Excipients Market Size and Forecast By Form, 2021-2031, ($Million)
8.2.3. North America Pharmaceutical Excipients Market Size and Forecast By Type , 2021-2031, ($Million)
8.2.4. North America Pharmaceutical Excipients Market Size and Forecast By Sales Channel 2021-2031, ($Million)
8.2.5. The U.S.
8.2.5.1. The U.S. Pharmaceutical Excipients Market Size and Forecast By Form, 2021-2031, ($Million)
8.2.5.2. The U.S. Pharmaceutical Excipients Market Size and Forecast By Type , 2021-2031, ($Million)
8.2.5.3. The U.S. Pharmaceutical Excipients Market Size and Forecast By Sales Channel 2021-2031, ($Million)
8.2.6. Canada
8.2.6.1. Canada Pharmaceutical Excipients Market Size and Forecast By Form, 2021-2031, ($Million)
8.2.6.2. Canada Pharmaceutical Excipients Market Size and Forecast By Type , 2021-2031, ($Million)
8.2.6.3. Canada Pharmaceutical Excipients Market Size and Forecast By Sales Channel 2021-2031, ($Million)
8.2.7. Mexico
8.2.7.1. Mexico Pharmaceutical Excipients Market Size and Forecast By Form, 2021-2031, ($Million)
8.2.7.2. Mexico Pharmaceutical Excipients Market Size and Forecast By Type , 2021-2031, ($Million)
8.2.7.3. Mexico Pharmaceutical Excipients Market Size and Forecast By Sales Channel 2021-2031, ($Million)
8.3. Europe
8.3.1. Key Market Trends and Opportunities
8.3.2. Europe Pharmaceutical Excipients Market Size and Forecast By Form, 2021-2031, ($Million)
8.3.3. Europe Pharmaceutical Excipients Market Size and Forecast By Type , 2021-2031, ($Million)
8.3.4. Europe Pharmaceutical Excipients Market Size and Forecast By Sales Channel 2021-2031, ($Million)
8.3.5. Germany
8.3.5.1. Germany Pharmaceutical Excipients Market Size and Forecast By Form, 2021-2031, ($Million)
8.3.5.2. Germany Pharmaceutical Excipients Market Size and Forecast By Type , 2021-2031, ($Million)
8.3.5.3. Germany Pharmaceutical Excipients Market Size and Forecast By Sales Channel 2021-2031, ($Million)
8.3.6. France
8.3.6.1. France Pharmaceutical Excipients Market Size and Forecast By Form, 2021-2031, ($Million)
8.3.6.2. France Pharmaceutical Excipients Market Size and Forecast By Type , 2021-2031, ($Million)
8.3.6.3. France Pharmaceutical Excipients Market Size and Forecast By Sales Channel 2021-2031, ($Million)
8.3.7. U.K.
8.3.7.1. U.K. Pharmaceutical Excipients Market Size and Forecast By Form, 2021-2031, ($Million)
8.3.7.2. U.K. Pharmaceutical Excipients Market Size and Forecast By Type , 2021-2031, ($Million)
8.3.7.3. U.K. Pharmaceutical Excipients Market Size and Forecast By Sales Channel 2021-2031, ($Million)
8.3.8. Spain
8.3.8.1. Spain Pharmaceutical Excipients Market Size and Forecast By Form, 2021-2031, ($Million)
8.3.8.2. Spain Pharmaceutical Excipients Market Size and Forecast By Type , 2021-2031, ($Million)
8.3.8.3. Spain Pharmaceutical Excipients Market Size and Forecast By Sales Channel 2021-2031, ($Million)
8.3.9. Italy
8.3.9.1. Italy Pharmaceutical Excipients Market Size and Forecast By Form, 2021-2031, ($Million)
8.3.9.2. Italy Pharmaceutical Excipients Market Size and Forecast By Type , 2021-2031, ($Million)
8.3.9.3. Italy Pharmaceutical Excipients Market Size and Forecast By Sales Channel 2021-2031, ($Million)
8.3.10. Rest of Europe
8.3.10.1. Rest of Europe Pharmaceutical Excipients Market Size and Forecast By Form, 2021-2031, ($Million)
8.3.10.2. Rest of Europe Pharmaceutical Excipients Market Size and Forecast By Type , 2021-2031, ($Million)
8.3.10.3. Rest of Europe Pharmaceutical Excipients Market Size and Forecast By Sales Channel 2021-2031, ($Million)
8.4. Asia-Pacific
8.4.1. Key Market Trends and Opportunities
8.4.2. Asia-Pacific Pharmaceutical Excipients Market Size and Forecast By Type , 2021-2031, ($Million)
8.4.3. Asia-Pacific Pharmaceutical Excipients Market Size and Forecast By Form, 2021-2031, ($Million)
8.4.4. Asia-Pacific Pharmaceutical Excipients Market Size and Forecast By Sales Channel 2021-2031, ($Million)
8.4.5. China
8.4.5.1. China Pharmaceutical Excipients Market Size and Forecast By Form, 2021-2031, ($Million)
8.4.5.2. China Pharmaceutical Excipients Market Size and Forecast By Type , 2021-2031, ($Million)
8.4.5.3. China Pharmaceutical Excipients Market Size and Forecast By Sales Channel 2021-2031, ($Million)
8.4.6. India
8.4.6.1. India Pharmaceutical Excipients Market Size and Forecast By Form, 2021-2031, ($Million)
8.4.6.2. India Pharmaceutical Excipients Market Size and Forecast By Type , 2021-2031, ($Million)
8.4.6.3. India Pharmaceutical Excipients Market Size and Forecast By Sales Channel 2021-2031, ($Million)
8.4.7. Japan
8.4.7.1. Japan Pharmaceutical Excipients Market Size and Forecast By Form, 2021-2031, ($Million)
8.4.7.2. Japan Pharmaceutical Excipients Market Size and Forecast By Type , 2021-2031, ($Million)
8.4.7.3. Japan Pharmaceutical Excipients Market Size and Forecast By Sales Channel 2021-2031, ($Million)
8.4.8. South Korea
8.4.8.1. South Korea Pharmaceutical Excipients Market Size and Forecast By Form, 2021-2031, ($Million)
8.4.8.2. South Korea Pharmaceutical Excipients Market Size and Forecast By Type , 2021-2031, ($Million)
8.4.8.3. South Korea Pharmaceutical Excipients Market Size and Forecast By Sales Channel 2021-2031, ($Million)
8.4.9. Rest of APAC
8.4.9.1. Rest of APAC Pharmaceutical Excipients Market Size and Forecast By Form, 2021-2031, ($Million)
8.4.9.2. Rest of APAC Pharmaceutical Excipients Market Size and Forecast By Type , 2021-2031, ($Million)
8.4.9.3. Rest of APAC Pharmaceutical Excipients Market Size and Forecast By Sales Channel 2021-2031, ($Million)
8.5. Rest of the World
8.5.1. Key Market Trends and Opportunities
8.5.2. Rest of the World Pharmaceutical Excipients Market Size and Forecast By Form, 2021-2031, ($Million)
8.5.3. Rest of the World Pharmaceutical Excipients Market Size and Forecast By Type , 2021-2031, ($Million)
8.5.4. Rest of the World Pharmaceutical Excipients Market Size and Forecast By Sales Channel 2021-2031, ($Million)
8.5.5. Latin America
8.5.5.1. Latin America Pharmaceutical Excipients Market Size and Forecast By Form, 2021-2031, ($Million)
8.5.5.2. Latin America Pharmaceutical Excipients Market Size and Forecast By Type , 2021-2031, ($Million)
8.5.5.3. Latin America Pharmaceutical Excipients Market Size and Forecast By Sales Channel 2021-2031, ($Million)
8.5.6. Middle East
8.5.6.1. Middle East Pharmaceutical Excipients Market Size and Forecast By Form, 2021-2031, ($Million)
8.5.6.2. Middle East Pharmaceutical Excipients Market Size and Forecast By Type , 2021-2031, ($Million)
8.5.6.3. Middle East Pharmaceutical Excipients Market Size and Forecast By Sales Channel 2021-2031, ($Million)
8.5.7. Africa
8.5.7.1. Africa Pharmaceutical Excipients Market Size and Forecast By Form, 2021-2031, ($Million)
8.5.7.2. Africa Pharmaceutical Excipients Market Size and Forecast By Type , 2021-2031, ($Million)
8.5.7.3. Africa Pharmaceutical Excipients Market Size and Forecast By Sales Channel 2021-2031, ($Million)

Chapter 9. Competitive Landscape
9.1. Market Overview
9.2. Market Share Analysis/Key Player Positioning
9.3. Developmental Strategy Benchmarking
9.3.1. New Product Development
9.3.2. Product Launches
9.3.3. Business Expansions
9.3.4. Partnerships, Joint Ventures, and Collaborations
9.3.5. Mergers and Acquisitions

Chapter 10. Company Profiles
10.1. Archer Daniels Midland Company
10.1.1. Pacific Foods of Oregon, Inc.
10.1.2. Financial Performance
10.1.3. Product Offerings
10.1.4. Key Strategic Initiatives
10.1.5. SWOT Analysis

10.2 BASF SE

10.1.1. Pacific Foods of Oregon, Inc.
10.1.2. Financial Performance
10.1.3. Product Offerings
10.1.4. Key Strategic Initiatives
10.1.5. SWOT Analysis

10.3 Evonik Industries AG

10.1.1. Pacific Foods of Oregon, Inc.
10.1.2. Financial Performance
10.1.3. Product Offerings
10.1.4. Key Strategic Initiatives
10.1.5. SWOT Analysis

10.4 The Lubrizol Corporation

10.1.1. Pacific Foods of Oregon, Inc.
10.1.2. Financial Performance
10.1.3. Product Offerings
10.1.4. Key Strategic Initiatives
10.1.5. SWOT Analysis

10.5 DuPont

10.1.1. Pacific Foods of Oregon, Inc.
10.1.2. Financial Performance
10.1.3. Product Offerings
10.1.4. Key Strategic Initiatives
10.1.5. SWOT Analysis

10.6 Archer Daniels Midland Company

10.1.1. Pacific Foods of Oregon, Inc.
10.1.2. Financial Performance
10.1.3. Product Offerings
10.1.4. Key Strategic Initiatives
10.1.5. SWOT Analysis

10.7 Ashland Global Holdings

10.1.1. Pacific Foods of Oregon, Inc.
10.1.2. Financial Performance
10.1.3. Product Offerings
10.1.4. Key Strategic Initiatives
10.1.5. SWOT Analysis

10.8 Roquette Feres

10.1.1. Pacific Foods of Oregon, Inc.
10.1.2. Financial Performance
10.1.3. Product Offerings
10.1.4. Key Strategic Initiatives
10.1.5. SWOT Analysis

10.9 Associated British Foods

10.1.1. Pacific Foods of Oregon, Inc.
10.1.2. Financial Performance
10.1.3. Product Offerings
10.1.4. Key Strategic Initiatives
10.1.5. SWOT Analysis

10.10 Croda International

10.1.1. Pacific Foods of Oregon, Inc.
10.1.2. Financial Performance
10.1.3. Product Offerings
10.1.4. Key Strategic Initiatives
10.1.5. SWOT Analysis

10.11 Innophous Holdings

10.1.1. Pacific Foods of Oregon, Inc.
10.1.2. Financial Performance
10.1.3. Product Offerings
10.1.4. Key Strategic Initiatives
10.1.5. SWOT Analysis

10.12 The Dow Chemical Company

10.1.1. Pacific Foods of Oregon, Inc.
10.1.2. Financial Performance
10.1.3. Product Offerings
10.1.4. Key Strategic Initiatives
10.1.5. SWOT Analysis

10.13 AkzoNobel NV

10.1.1. Pacific Foods of Oregon, Inc.
10.1.2. Financial Performance
10.1.3. Product Offerings
10.1.4. Key Strategic Initiatives
10.1.5. SWOT Analysis

10.14 W.R. Grace & Co.

10.1.1. Pacific Foods of Oregon, Inc.
10.1.2. Financial Performance
10.1.3. Product Offerings
10.1.4. Key Strategic Initiatives
10.1.5. SWOT Analysis

10.15 Celanese Corporation

10.1.1. Pacific Foods of Oregon, Inc.
10.1.2. Financial Performance
10.1.3. Product Offerings
10.1.4. Key Strategic Initiatives
10.1.5. SWOT Analysis

*The list of company is subject to change during the final compilation of the report

 

 

Market Segments

By Type

  • Functional Beverage
  • Functional Food
  • Dietary Supplement

By Form

  • Capsule and Tablets
  • Liquid
  • Powder
  • Others

By Sales Channel

  • Hypermarket/Supermarket
  • Specialty Stores
  • Pharmacy
  • Online Channels

By Region

  • North America
    • The U.S.
    • Canada
    • Mexico
  • Europe
    • The UK
    • Germany
    • France
    • Spain
    • Rest of Europe
  • The Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Rest of the World
    • Latin America
    • The Middle East
    • Africa

Order this Report

Have questions about the scope of the report ?

Have specific requirements ?

Budget Constraints ?

Related Reports

Probiotics are live bacteria that are beneficial to…
Quinoa seeds are small, round-shaped, edible seeds that…
Pheromones are chemical signals that are released by…
The Hibiscus Flower Powder Market size was USD…
Cat food is a type of animal feed…
Flavonoids are a type of phytonutrient, which are…
Microcrystalline Cellulose (MCC) is a type of refined…
Collagen and gelatin are two proteins that are…
Egg white cubes are a type of egg…
The global food processing ingredients market was valued…